FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Medical Device eCopy Submission Guidance

FDA publishes a guidance on implementing the eCopy submission program for medical devices.

latest-news-card-1
Medical Devices

FDA, CMS Launching Tempo Pilot

FDA launches a pilot with the Center for Medicare and Medicaid Innovation to promote access to certain digital health devices covered through a new Ce...

latest-news-card-1
Human Drugs

User Fees Could Incentivize U.S. Drug Development

FDA reportedly is exploring ways PDUFA fees can be adjusted to incentivize companies to hold clinical trials in the U.S. rather than overseas.

latest-news-card-1

Quarter 3 Drug and Device Recalled Units Higher: Sedgwick Index

The Sedgwick third-quarter recall index sees a sharp increase in the number of affected drug and medical device units.

Biologics

Prasad Defends Vaccine Policy Shift: Report

CBER director Vinay Prasad addresses a 12/4 investor conference in New York and defends his leadership, and attributing criticism to "misleading media...

latest-news-card-1
Human Drugs

CDER Compliance Chief Details Compliance Shifts

CDER Office of Compliance director Jill Furman highlights a year of sweeping operational shifts, heightened enforcement, and emerging use of artificia...

latest-news-card-1
FDA General

Biden Admin Buried Covid Myocarditis Data: Makary

FDA commissioner Marty Makary alleges that the Biden administration failed to disclose internal data on myocarditis risks in young people following Co...

latest-news-card-1
Human Drugs

Bayesian Statistical Analysis Demonstration Project

FDA solicits proposals for the CDER Center for Clinical Trial Innovation Bayesian Statistical Analysis demonstration project.

latest-news-card-1
Biologics

CBER Inspections Challenged by Lack of Facility Readiness

CBER says that a common deficiency that is driving a significant share of BLA-related complete response letters is manufacturing facility inspection r...

latest-news-card-1
Human Drugs

Clinical Hold Lifted on Vandas Motion Sickness Studies

FDA lifts a partial clinical hold on one of Vanda Pharmaceuticals key tradipitant studies, clearing the company to expand dosing in an ongoing motion-...